Artificial intelligence has moved quickly from experimentation to real use inside the finance function. Controllers, chief accounting officers and CFOs are being asked to evaluate how AI can support ...

A unanimous Supreme Court reversed the Federal Circuit and held that Amarin did not plausibly allege that Hikma’s skinny label and marketing actively induced infringement of Vascepa’s ...

Each day, millions of people pick up a prescription drug from their local pharmacy or mailbox. Most are affordable, with co-pays on average less than $7 for 90% of drugs. But for a growing number of ...

In recent weeks, Canada became the first G7 country to approve a generic version of the popular drug Ozempic. Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to ...

Hims & Hers Health (HIMS) on Thursday announced the launch of generic versions of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy semaglutide through its telehealth platform in Canada. The ...

The Trump administration is joining forces with Mark Cuban’s Cost Plus Drugs, Amazon Pharmacy, and GoodRx to add generic medications to the direct-to-consumer drug sales website, TrumpRx, in an ...

Consider this question: Why do we like the music we like? Were we born with musical preferences, or did we develop them over time through life experiences? This post, Part 2 of a 3-Part series, ...

Americans are unlikely to see generic versions of semaglutide — the active ingredient in Novo Nordisk’s Ozempic and Wegovy — until at least the end of 2031, according to a May 13 NBC News report. Novo ...

India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic? Limited time: Save 25% on NBC News subscription Get ...

This is part of a series of columns about the viability of the American university system. Last week, I asked whether, as a forty-six-year-old father of two, I should keep contributing to my ...

The chief executive of generic-drug maker Sandoz SDZ0.35%increase; up pointing triangle Group expects the market for unbranded versions of popular weight-loss medicines to be big. Just how big, though ...